Table 3 Drug use (past 30 days) and risk behaviour of the drug users in Kathmandu Valley ( N = 300)
No cocktail use | Moderate use | Intensive use | Significancea (χ2, ANOVA) | |
|---|---|---|---|---|
Alcohol | 66.7% | 66.7% | 60.6% | χ2 = 1.2, p = .558 |
Number of days | 19.1 (±11.7) | 22.1 (±10.0) | 18.6 (±10.4) | F = 2.4, p = .098 |
Heroin | 81.4% x, y | 29.4% x, z | 51.0% y, z | χ2 = 33.9, p < .001 |
Number of days | 27.0 (±7.4) x, y | 13.8 (±10.6) x | 16.0 (±10.2) y | F = 19.5, p < .001 |
Cannabis | 69.8% x | 87.3% x | 80.0% | χ2 = 6.2, p < .05 |
Number of days | 24.8 (±9.1) | 21.7 (±9.6) | 24.0 (±8.1) | F = 2.5, p = .088 |
Benzodiazepines | 27.9% x, y | 94.1% x | 89.7% y | χ2 = 103.1, p < .001 |
Number of days | 22.6 (±9.4) | 25.0 (±8.8) | 26.2 (±6.8) | F = 1.7, p = .193 |
Chewing tobacco | 25.6% y | 39.2% z | 52.3% y, z | χ2 = 11.2, p < .01 |
Number of days | 23.5 (±9.1) | 24.5 (±9.1) | 21.3 (±9.9) | F = 1.5, p = .229 |
Number of different substances | 4.7 (±1.8) x, y | 6.0 (±1.5) x | 6.5 (±1.9) y | F = 17.7, p < .001 |
Use of 10-ml syringes | 11.8% x, y | 61.8% x | 56.9% y | χ2 = 14.9, p < .001 |
Multiple use of the same needle | 45.0% x, y | 69.6% x | 74.8 y | χ2 = 13.3, p < .01 |
Needle/equipment sharing | 48.8% y | 61.8% z | 90.3% y, z | χ2 = 43.8, p < .001 |
N | 43 | 102 | 155 |